Connealy Pamela Ann

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Connealy Pamela Ann's trades of Pyxis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
12.23
Quantity 42,407 +35.3%
Value US$1,735,459
Transaction date
Purchase
Price
386.65
Quantity 90,826 +24.1%
Value US$1,993,881
Transaction date
Purchase
Price
481.51
Quantity 37,761 +38.5%
Value US$3,257,471
Transaction date
Purchase
Price
1.85
Quantity 6,426 +0.8%
Value US$11,868
Transaction date
Purchase
Price
1.67
Quantity 12,000 +1.5%
Value US$20,044
Transaction date
Purchase
Price
1.74
Quantity 5,000 +0.6%
Value US$8,695
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-27 2024-11-26
B Purchase
42,407 +35.3%
12.23
US$1,735,459 		42,407 +35.3% 12.23 US$1,735,459
2024-11-27 2024-11-26
B Purchase
90,826 +24.1%
386.65
US$1,993,881 		90,826 +24.1% 386.65 US$1,993,881
2023-09-28 2023-09-28
B Purchase
37,761 +38.5%
481.51
US$3,257,471 		37,761 +38.5% 481.51 US$3,257,471
2023-09-27 2023-09-27
B Purchase
6,426 +0.8%
1.85
US$11,868 		6,426 +0.8% 1.85 US$11,868
2023-09-25 2023-09-25
B Purchase
12,000 +1.5%
1.67
US$20,044 		12,000 +1.5% 1.67 US$20,044
2023-09-22 2023-09-22
B Purchase
5,000 +0.6%
1.74
US$8,695 		5,000 +0.6% 1.74 US$8,695